MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$24,480,848
Loss before
provision for income taxes
-$24,480,848
Loss from operations
-$19,351,291
Total other expense,
net
-$5,129,557
Change in fair value of
liabilities
$3,860,889
Total operating
expenses
$19,351,175
Gross margin
-$116
Interest expense
$8,531,275
Net revenue
$6,202
Loss on
extinguishment of debt
-$364,109
Initial recognition of
forward purchase...
-$95,062
General and
administrative (including...
$17,637,432
Research and development
$923,914
Sales and marketing
$789,829
Cost of revenue
$6,318
Back
Back
Income Statement
source: myfinsight.com
Aspire Biopharma Holdings, Inc. (ASBP)
Aspire Biopharma Holdings, Inc. (ASBP)